Compare TLF & CING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TLF | CING |
|---|---|---|
| Founded | 1980 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Apparel | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 22.0M | 27.0M |
| IPO Year | N/A | 2021 |
| Metric | TLF | CING |
|---|---|---|
| Price | $2.67 | $3.99 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $32.67 |
| AVG Volume (30 Days) | 19.3K | ★ 128.7K |
| Earning Date | 11-10-2025 | 11-13-2025 |
| Dividend Yield | ★ 56.18% | N/A |
| EPS Growth | ★ 308.92 | N/A |
| EPS | ★ 1.18 | N/A |
| Revenue | ★ $74,550,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $2.27 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.56 | $3.20 |
| 52 Week High | $5.48 | $6.01 |
| Indicator | TLF | CING |
|---|---|---|
| Relative Strength Index (RSI) | 39.34 | 60.32 |
| Support Level | $2.68 | $3.80 |
| Resistance Level | $2.79 | $3.99 |
| Average True Range (ATR) | 0.14 | 0.20 |
| MACD | 0.01 | 0.06 |
| Stochastic Oscillator | 30.56 | 96.93 |
Tandy Leather Factory Inc is a specialty retailers of leather and leathercraft-related items. Its primary line of business is the sale of leather, leather crafts, and related supplies. Its broad line of leather and related products includes leather, leatherworking tools, leather dyes and finishes, and do-it-yourself kits. Its products include Leather, tools, Hardware, Supplies, Kits, Books and Patterns, and Gift cards. The company sells its products primarily through company-owned stores and through orders generated from its global websites, and through direct account representatives in its commercial division. Geographically the company operates within the United States, Canada and others and generates the highest revenue from the United States.
Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.